Insights
AI Moving from Pilot to Embedded Practice — With a Governance Gap
Introduction Artificial Intelligence and Machine Learning are no longer distant promises in clinical research. For several years, AI has been discussed as a potential accelerator for clinical trials, often through
Featured Insights
Gene therapy trials: A new era of personalized medicine
Introduction Gene therapy, once seen as a distant promise, is now at the heart of a medical revolution, marking the advent of a new era: that of personalized medicine. Unlike
Psychiatric clinical trials: addressing methodological challenges
Introduction Psychiatric clinical trials are vital to advancing the treatment and understanding of mental health disorders. This emphasizes the need for biomarkers to enhance psychiatric treatments, particularly for disorders like
Clinical clues to caring for aging, complex patients
Introduction The increase in multimorbidity among elderly patients presents a major challenge for healthcare systems, especially within the context of clinical trials [1]. As the population ages, the complexity of
The future of cancer treatment: Insights from immunotherapy trials
INTRODUCTION Cancer remains one of the most significant challenges in modern medicine, affecting millions of lives globally each year. , with an estimated 1.9 million new cases and 609,360 deaths
Pricing pressures and access to medicine – rethinking commercial strategies & drug development costs to improve affordability in lower-income markets
Introduction Access to medicines in low-income markets remains a significant challenge, exacerbated by pricing pressures and high drug development costs. Populations in these regions often face limited access to essential
Five Innovative Approaches to Overcome Placebo Response in Clinical Trials
Introduction In clinical trials, the placebo effect presents a formidable challenge. Placebos, inert substances, or treatments given to control groups, can lead to apparent improvements in symptoms solely through patients’
